Clinical Trials
910 trialsChemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer
Peking Union Medical College Hospital
Radiotherapy Treatments for Neoplasms in the Abdominal-pelvic Region
European Institute of Oncology
PILLAR
Jules Bordet Institute
the Predictive Value of Immune Cell in Locally Advanced Cervical Cancer
RenJi Hospital
Inflammatory Index as a Predictor for Endometrial Cancer: an Observational Study
University of Campania Luigi Vanvitelli
CERTIFIKO
University of Campania Luigi Vanvitelli
MTTRIHPW
Obstetrics & Gynecology Hospital of Fudan University
Plasma Metabolic Biomarkers for Multi-Cancer Diagnosis
Beijing Friendship Hospital
PEACOCC
University College, London
STILVARCA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
LIBRE-2
Technical University of Munich
A Novel Smart Speculum Versus a Standard Speculum for Easy Visualisation of the Cervix and Performing Remote Cervical Cancer Screening
GICMED
Eternity
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano
Exploring the Potential of ctDNA-MRD for Recurrence Surveillance and Prognostic Evaluation in High-risk Endometrial Cancer
The First Hospital of Jilin University
PANO
Dublin City University
The Epigenetic Regulatory Role of P-element Induced Wimpy Testis (Piwi) Interacting RNA-823 (piR-823) in Ovarian Cancer Progression
Ain Shams University
Artificial Intelligence Model for Growth Prediction of Ovarian Cancer Organoids
Chongqing University Cancer Hospital
FERTILAVE
Hospices Civils de Lyon
Pemb-HT
University Health Network, Toronto
BRCA 1/2 Status as a Predictive Factor to Response to Platinum Based Chemotherapy in Cancer Ovary
Assiut University
Study on TIL for the Treatment of r/r Gynecologic Tumors
Shanghai 10th People's Hospital
TITANIUM
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
DCE-MRI
University Hospital, Ghent
PROVIDENCE
Hospital Clinic of Barcelona
Romantic
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
PITHAC
Centre Hospitalier Universitaire Vaudois
Nab-PIPAC
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
GARD-HIPEC
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
LUXA
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
CECIL
University of Santo Tomas Hospital, Philippines
DORA
Grupo Español de Investigación en Cáncer de Ovario
SUCCEEDER
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
From Fetal-maternal Interface Immune Tolerance to Endometrial Cancer Immune Escape: Potential Targets for Immunotherapy
Regina Elena Cancer Institute
Preventing Ovarian Cancer Through Oportunistic Salpingectomy at the Time of Colorectal Surgery
University of British Columbia
NIECE
Assistance Publique - Hôpitaux de Paris
POSVUC
Sahlgrenska University Hospital
VUBAR
Universitair Ziekenhuis Brussel
Management With Fear of Cancer in Women Undergoing Colposcopy: Randomized Controlled Study
Alanya Alaaddin Keykubat University
Family History Study on Cancer Risk
Kaiser Permanente
VICTORIA
Centre Leon Berard
The IIT Study of Evaluation of P-IL-2 Single Agent and With Anti-PD-1
Zhejiang University
BENITA
Universitätsklinikum Hamburg-Eppendorf
SENTIREC II
University of Southern Denmark
Effects of Decision Aids on the Participation of South Asian Women in Cervical Cancer Screening
Chinese University of Hong Kong
Study of Neoadjuvant Chemotherapy Versus Definite Concurrent Chemoradiotherapy for Locally Advanced Bulk Cervical Cancer
Shantou University Medical College
Dalpiciclib Combined With Letrozole in HR+/HER2 - Gynecologic Solid Tumors
Peking Union Medical College Hospital
Lenvatinib Plus Toripalimab for Platinum-Resistant Recurrent Ovarian Cancer
Peking Union Medical College Hospital
HER2 Expression in Gynecological Malignant Tumors in Chongqing Area of China
Chongqing University Cancer Hospital
Predicting the Risk of Ovarian Cancer Recurrence Using Circulating Tumor DNA to Assess Residual Disease
Allegheny Singer Research Institute (also known as Allegheny Health Network Research Institute)
IACOL
Assistance Publique - Hôpitaux de Paris